IRBM Science Park is an Italian firm that specializes in molecular biotechnology, medicinal research, and organic chemistry.
IRBM has developed unique expertise in advancing integrated drug discovery projects, having delivered 25 preclinical candidates and four drugs that are currently on the market. With all their world-class facilities on-site, fully integrated programs are executed under one roof. IRBM works with pharmaceutical companies, non-profit organizations and academic institutions, to quickly and efficiently advance their projects through the drug discovery and development pipeline.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 21, 2022 | Debt Financing | €15M | 1 | European Investment Bank | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European Investment Bank | Yes | Debt Financing |